Pamidronate disodium pentahydrate (Standard)

Cat. No.: HY-B0730R Purity: ≥98%: Handling Instructions Technical Support

Pamidronate (disodium pentahydrate) (Standard) is the analytical standard of Pamidronate (disodium pentahydrate). This product is intended for research and analytical applications. Pamidronate disodium pentahydrate, the second-generation nitrogen-containing bisphosphonate, is an inhibitor of bone loss. Pamidronate disodium pentahydrate significantly inhibits subchondral bone loss in early osteoarthritis by upregulating the expression of osteoprotegerin in cartilage and subchondral bone, and inhibiting the expression of RANKL and MMP-9 in both tissues, as well as TLR-4 in cartilage, thereby alleviating cartilage degeneration. Additionally, Pamidronate disodium pentahydrate can inhibit the signaling of Wnt and β-catenin, and is applicable for research on osteoporosis and osteosarcoma.

For research use only. We do not sell to patients.

Pamidronate disodium pentahydrate (Standard) Chemical Structure

CAS No. : 109552-15-0

Size	Price	Stock	Quantity
5 mg	USD 92	Get quote 5 - 7 weeks 4 - 6 weeks 4-6 weeks	4-6 weeks
10 mg	USD 137	Get quote 5 - 7 weeks 4 - 6 weeks 4-6 weeks	4-6 weeks
25 mg	USD 247	Get quote 5 - 7 weeks 4 - 6 weeks 4-6 weeks	4-6 weeks
50 mg	USD 371	Get quote 5 - 7 weeks 4 - 6 weeks 4-6 weeks	4-6 weeks
100 mg	USD 520	Get quote 5 - 7 weeks 4 - 6 weeks 4-6 weeks	4-6 weeks
200 mg		Get quote
500 mg		Get quote

Synthetic products have potential research and development risk.

or Bulk Inquiry

* Please select Quantity before adding items.

Customer Review

Based on 1 publication(s) in Google Scholar

Product Information
Purity & Documentation
Customer Review

Description	Pamidronate (disodium pentahydrate) (Standard) is the analytical standard of Pamidronate (disodium pentahydrate). This product is intended for research and analytical applications. Pamidronate disodium pentahydrate , the second-generation nitrogen-containing bisphosphonate, is an inhibitor of bone loss. Pamidronate disodium pentahydrate significantly inhibits subchondral bone loss in early osteoarthritis by upregulating the expression of osteoprotegerin in cartilage and subchondral bone, and inhibiting the expression of RANKL and MMP-9 in both tissues, as well as TLR-4 in cartilage, thereby alleviating cartilage degeneration. Additionally, Pamidronate disodium pentahydrate can inhibit the signaling of Wnt and β-catenin, and is applicable for research on osteoporosis and osteosarcoma.
Molecular Weight	369.11
Formula	C₃H₁₉NNa₂O₁₂P₂
CAS No.	109552-15-0
SMILES	OC(P(O)(O[Na])=O)(CCN)P(O)(O[Na])=O.O.O.O.O.O
Storage	Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation	Handling Instructions (2659 KB)